Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
[Preprint]. 2023 Jun 10:2023.06.06.23290983.
doi: 10.1101/2023.06.06.23290983.

Low-Field Combined Diffusion-Relaxation MRI for Mapping Placenta Structure and Function

Affiliations

Low-Field Combined Diffusion-Relaxation MRI for Mapping Placenta Structure and Function

Paddy J Slator et al. medRxiv. .

Abstract

Purpose: Demonstrating quantitative multi-parametric mapping in the placenta with combined T2-diffusion MRI at low-field (0.55T).

Methods: We present 57 placental MRI scans performed on a commercially available 0.55T scanner. We acquired the images using a combined T2-diffusion technique scan that simultaneously acquires multiple diffusion preparations and echo times. We processed the data to produce quantitative T2 and diffusivity maps using a combined T2-ADC model. We compared the derived quantitative parameters across gestation in healthy controls and a cohort of clinical cases.

Results: Quantitative parameter maps closely resemble those from previous experiments at higher field strength, with similar trends in T2 and ADC against gestational age observed.

Conclusion: Combined T2-diffusion placental MRI is reliably achievable at 0.55T. The advantages of lower field strength - such as cost, ease of deployment, increased accessibility and patient comfort due to the wider bore, and increased T2 for larger dynamic ranges - can support the widespread roll out of placental MRI as an adjunct to ultrasound during pregnancy.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
Exemplary direction-averaged data for three TEs and four b-values after denoising for a single control participant with GA = 27.14 weeks. See Figure 2 for derived maps for this participant.
Figure 2:
Figure 2:
Detailed view into one example dataset (control, GA = 27.14 weeks - same participant as Figure 1). Top row: the ADC and T2 map from the joint fit. Bottom row: the T2 map from the additional multi-echo gradient echo scan. The blue arrow shows the increased ADC and T2 in the lobule centres, the pink arrow the increase on the chorionic plate and the orange arrows the increase in ADC and reduction in T2 in the septa between the lobules.
Figure 3:
Figure 3:
T2 maps across gestation from joint T2-diffusivity model fit to the protocol 1 combined T2-diffusion data. Subplot titles give the gestational age in weeks and text color denotes the cohort.
Figure 4:
Figure 4:
diffusivity maps across gestation from joint T2-diffusivity model fit to the protocol 1 combined T2-diffusion data.
Figure 5:
Figure 5:
T2 maps across gestation from joint T2-diffusivity model fit to the protocol 2 combined T2-diffusion data.
Figure 6:
Figure 6:
diffusivity maps across gestation from joint T2-diffusivity model fit to the protocol 2 combined T2-diffusion data.
Figure 7:
Figure 7:
Mean T2 and ADC values over gestational age across the cohorts for protocol 1 (b=0, 50, 100, 150, 300, 500, 750, 1000 s/mm2) and protocol 2 (b=0, 20, 30, 50, 70, 100, 120 150, 300, 500, 750, 1000 s/mm2). Lines indicate the same participant scanned twice. Arrow in panel A indicates outlier scan with a clear contraction (see Discussion).
Figure 8:
Figure 8:
Estimated T2 (panel A) and ADC (panel B) values for both combined T2-diffusion protocols.
Figure 9:
Figure 9:
A) Mean T2 values against gestation from monoexponential T2 fit to standard multi-echo gradient echo scan. B) Mean placental T2 values from joint model fit to combined T2-diffusion scan (protocol 1) against mean placental T2 values from fit to standard multi-echo gradient echo scan. C) As middle panel but for protocol 2.

Similar articles

References

    1. Burton GJ, Jauniaux E. What is the placenta? Am J Obstet Gynecol. 2015;213: S6.e1, S6–8. - PubMed
    1. Burton GJ, Fowden AL. The placenta: a multifaceted, transient organ. Philos Trans R Soc Lond B Biol Sci. 2015;370: 20140066. - PMC - PubMed
    1. Brosens I, Pijnenborg R, Vercruysse L, Romero R. The “Great Obstetrical Syndromes” are associated with disorders of deep placentation. Am J Obstet Gynecol. 2011;204: 193–201. - PMC - PubMed
    1. Turco MY, Moffett A. Development of the human placenta. Development. 2019;146. doi:10.1242/dev.163428 - DOI - PubMed
    1. Rolnik DL, Wright D, Poon LC, O’Gorman N, Syngelaki A, de Paco Matallana C, et al. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. N Engl J Med. 2017;377: 613–622. - PubMed

Publication types